TCR2 THERAPEUTICS INC. Quarterly Common Stock, Shares, Issued from Q4 2018 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Tcr2 Therapeutics Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2018 to Q1 2023.
  • Tcr2 Therapeutics Inc. Common Stock, Shares, Issued for the quarter ending March 31, 2023 was 39.2M shares, a 1.81% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 39.2M +698K +1.81% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 39.2M +707K +1.84% Dec 31, 2022 10-Q 2023-05-11
Q3 2022 38.7M +437K +1.14% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 38.6M +418K +1.09% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 38.5M +387K +1.02% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 38.5M +4.98M +14.9% Dec 31, 2021 10-K 2023-03-23
Q3 2021 38.2M +4.82M +14.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 38.2M +14M +58.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 38.2M +14.1M +58.5% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 33.5M +9.47M +39.4% Dec 31, 2020 10-K 2022-03-22
Q3 2020 33.4M +9.36M +39% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 24.1M +175K +0.73% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 24.1M +136K +0.57% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 24.1M +23.1M +2530% Dec 31, 2019 10-K 2021-03-16
Q3 2019 24M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 24M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 23.9M Mar 31, 2019 10-Q 2019-05-13
Q4 2018 915K Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.